Pay in 4 interest-free payments of $32.73 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
Na/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16
is a small molecule inhibitor of polycomb repressive complex 1
5-a]pyrimidin-3-yl)benzamide
Welling DB
20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer
AMD-070 Catalog No.:M10820-10 Na/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16Mavorixafor, also known as AMD11070, AMD070, X4P 001, is an orally bioavailable and potent CXCR4 inhibitor. AMD11070 is an antagonist of SDF 1 ligand binding (IC50 = 12. 5 1. 3 nM), inhibits SDF 1 mediated calcium flux (IC50 = 9. 0 2. 0 nM) and SDF 1 mediated activation of the CXCR4 receptor as measured by a Eu GTP binding assay (IC50 =39. 8 2. 5 nM) or a [(35)S] GTPS binding assay (IC50 =19. 0 4. 1 nM), and inhibits SDF 1 stimulated chemotaxis (IC50
US$ 11.00
US$ 37.99
US$ 31.99